Ardent Health (NYSE:ARDT) Releases Earnings Results, Misses Estimates By $0.06 EPS

Ardent Health (NYSE:ARDT) posted its quarterly earnings data on Tuesday. The company reported $0.12 EPS for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.06), FiscalAI reports. The business had revenue of $1.62 billion for the quarter, compared to analyst estimates of $1.59 billion. Ardent Health had a return on equity of 13.85% and a net margin of 2.09%. Ardent Health updated its FY 2026 guidance to 0.780-1.150 EPS.

Ardent Health Stock Performance

NYSE ARDT traded down $0.01 during trading on Tuesday, reaching $10.74. 413,404 shares of the company’s stock were exchanged, compared to its average volume of 461,914. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.12 and a quick ratio of 2.00. The business has a 50 day moving average price of $9.83 and a 200-day moving average price of $9.43. The stock has a market capitalization of $1.54 billion, a P/E ratio of 11.30, a PEG ratio of 2.51 and a beta of 0.70. Ardent Health has a fifty-two week low of $7.71 and a fifty-two week high of $15.48.

Insider Activity

In other Ardent Health news, CFO Alfred Lumsdaine bought 10,000 shares of Ardent Health stock in a transaction dated Friday, June 5th. The stock was bought at an average cost of $8.81 per share, for a total transaction of $88,100.00. Following the purchase, the chief financial officer owned 329,183 shares of the company’s stock, valued at $2,900,102.23. The trade was a 3.13% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.90% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Ardent Health

Large investors have recently added to or reduced their stakes in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Ardent Health by 103.8% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 14,104 shares of the company’s stock valued at $194,000 after purchasing an additional 7,182 shares during the last quarter. Goldman Sachs Group Inc. boosted its position in Ardent Health by 1,684.9% during the first quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company’s stock worth $10,558,000 after purchasing an additional 724,841 shares during the period. Jane Street Group LLC increased its holdings in shares of Ardent Health by 235.1% in the first quarter. Jane Street Group LLC now owns 57,468 shares of the company’s stock valued at $790,000 after purchasing an additional 40,318 shares during the last quarter. Acadian Asset Management LLC increased its holdings in shares of Ardent Health by 574.9% in the first quarter. Acadian Asset Management LLC now owns 40,238 shares of the company’s stock valued at $550,000 after purchasing an additional 34,276 shares during the last quarter. Finally, Geode Capital Management LLC raised its position in shares of Ardent Health by 0.6% in the second quarter. Geode Capital Management LLC now owns 286,848 shares of the company’s stock valued at $3,918,000 after purchasing an additional 1,769 shares during the period.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the company. Truist Financial reduced their price target on Ardent Health from $13.00 to $12.00 and set a “buy” rating for the company in a research report on Tuesday, July 14th. Wall Street Zen downgraded Ardent Health from a “buy” rating to a “hold” rating in a report on Sunday, July 12th. UBS Group raised their target price on shares of Ardent Health from $13.00 to $13.50 and gave the company a “buy” rating in a research note on Thursday, May 7th. Royal Bank Of Canada lowered their target price on shares of Ardent Health from $13.00 to $12.00 and set an “outperform” rating on the stock in a report on Thursday, July 9th. Finally, Weiss Ratings reiterated a “sell (d+)” rating on shares of Ardent Health in a research note on Friday, June 12th. Seven investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, Ardent Health presently has a consensus rating of “Hold” and a consensus target price of $14.04.

About Ardent Health

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.